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Abstract
Inherited mitochondrial DNA (mtDNA) mutations cause mitochondrial disease, but mtDNA mutations also occur
somatically and accumulate during ageing. Studies have shown that the mutation load of some inherited mtDNA
mutations decreases over time in blood, suggesting selection against the mutation. However, it is unknown whether
such selection occurs in other mitotic tissues, and where it occurs within the tissue. Gastrointestinal epithelium
is a canonical mitotic tissue rapidly renewed by stem cells. Intestinal crypts (epithelium) undergo monoclonal
conversion with a single stem cell taking over the niche and producing progeny. We show: (1) that there is a
significantly lower mtDNA mutation load in the mitotic epithelium of the gastrointestinal tract when compared to
the smooth muscle in the same tissue in patients with the pathogenic m.3243A>G and m.8344A>G mutations;
(2) that there is considerable variation seen in individual crypts, suggesting changes in the stem cell population; (3)
that this lower mutation load is reflected in the absence of a defect in oxidative phosphorylation in the epithelium.
This suggests that there is selection against inherited mtDNA mutations in the gastrointestinal stem cells that is
in marked contrast to the somatic mtDNA mutations that accumulate with age in epithelial stem cells leading to
a biochemical defect.
© 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain
and Ireland.
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Introduction
Mitochondria are ubiquitous organelles present
in eukaryotic cells, a major function of which is to gen-
erate ATP via the process of oxidative phosphorylation
(OXPHOS). Mitochondria contain their own DNA
(mtDNA), which encodes 13 essential protein subunits
of the OXPHOS system, 22 tRNAs and 2 rRNAs. Each
cell contains multiple copies of mtDNA. Cells may be
homoplasmic, where all the copies of mitochondrial
DNA are identical, or heteroplasmic, with a mixture
of mutated and wild-type mtDNA molecules. The vast
majority of mtDNAmutations are functionally recessive
and an OXPHOS defect only occurs when the mutation
load exceeds a critical threshold [1].
Mutations of mtDNA are a common cause of
human inherited disease [2], but they also accumulate
somatically in tissues such as skeletal muscle, intestinal
epithelium, and blood with age [3–5]. In patients
with primary heteroplasmic mtDNA disease, despite
uniform mutation load across all tissues during foetal
development [6–8], some mtDNA mutations show a
decrease in the mutation load with age in blood and a
few epithelial tissues [9–11]. This suggests that mitotic
tissue may selectively lose inherited mtDNA muta-
tions over time. This is in marked contrast to somatic
mtDNA mutations that accumulate in such tissues
with age [4,5,12]. In addition, it is unknown whether
the loss of inherited mtDNA mutations is a common
feature for all mitotic tissues and where it happens
in the tissue. To address some of these questions, we
have investigated germline pathogenic heteroplasmic
mtDNA mutations in gastrointestinal stem cell popula-
tions. We compared OXPHOS activity, mitochondrial
protein expression, and mutation load in the epithe-
lium and smooth muscle of the oesophagus, stomach,
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Figure 1. Lower levels of m.3243A>G and m.8344A>G detected in the mitotic epithelium compared with the post-mitotic smooth muscle
of GI tract tissues. (A) Representative images of laser-microdissected (i) intestinal crypts and smooth muscles before (ii) and after (iii) laser
microdissection. (B) Quantitative pyrosequencing showing the mutation levels of inherited m.3243A>G in the epithelium and the smooth
muscle of the oesophagus, the stomach, the small intestine (SI), and the colon from three patients, and inherited m.8344A>G in the colonic
epithelium and smooth muscle of one patient. Each replicate represents DNA extracted from five pooled crypts of the intestines, five gastric
pits of the stomach or five small areas of smooth muscle. Oesophageal DNA was obtained from the tissue laser cut as an intact area in a
field of view. P1 SI (ne = 10, nm = 10), P2 oesophagus (ne = 10, nm = 10), P2 stomach (ne = 10, nm = 10), P2 SI (ne = 10, nm = 9), P3 colon
(ne = 10, nm = 10), P4 colon (ne = 20, nm = 10). *p< 0.05, **p< 0.005, and ****p< 0.0001 by unpaired t-test or Mann–Whitney U-test based
on the normality of the data.
and the small and large intestines of patients with the
common inherited m.3243A>G mtDNA variant within
MT-TL1 (encoding mitochondrial tRNALeu(UUR)) and
m.8344A>G mtDNA variant within MT-TK (encoding
mitochondrial tRNALys).
Materials and methods
Patients
Gastrointestinal tissue samples were collected from
three patients with m.3243A>G (patient 1 following
ileum resection at the age of 30; patients 2 and 3, aged
36 and 64, respectively at post-mortem) and from one
patient with m.8344A>G aged 56. Control tissue was
either taken during endoscopy from patients in whom no
pathology was found or at resection for colon cancer at a
distance of > 20 cm from the neoplasm. Details of the
subjects may be found in the supplementary material,
Supplementary materials and methods and Tables S1
and S2. Ethical approval was obtained from Newcastle
and North Tyneside LREC.
Pyrosequencing
Epithelial crypts and smooth muscle fibres were ran-
domly selected and laser-microdissected using a PALM
Laser microdissection system (Zeiss, Jena, Germany)
(Figure 1A). Total DNA was extracted by cell lysis
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as previously described [13]. PyroMark Assay design
software v2.0 (QIAGEN, Hilden, Germany) was used
to design the primer trio for pyrosequencing (supple-
mentary material, Table S3). Heteroplasmy levels were
quantified using the PyroMark Q96 software according
to the manufacturer’s instructions.
Sequential Cytochrome c Oxidase/Succinate
Dehydrogenase (COX/SDH) histochemistry
Sequential COX/SDH histochemistry was carried
out as previously described [4]. Quantification of
COX deficiency was calculated as the proportion of
COX-deficient crypts by all the crypts counted on two
sections.
Immunofluorescence
Quadruple immunofluorescence was performed as pre-
viously described [14]. Details of the antibodies used
may be found in the supplementary material, Table S4.
The optical density of the fluorescent images was mea-
sured by ImageJ. Background correction and the method
to determine the parameters (mean and standard devia-
tion, SD) of the control population have been described
formerly [14]. The Z-score of each respiratory chain
subunit for the disease case was calculated and cate-
gorised based on the normal population. For NDUFB8,
the level was classified as ‘negative’ (< −3 SD), ‘inter-
mediate’ (−3 to −2 SD) or ‘positive’ (> −2 SD). For
the non-mtDNA encoded proteins COX4 and SDHA, the
levels were categorised as ‘low’ (< −2 SD), ‘normal’
(−2 to 2 SD) or ‘high’ (> 2 SD).
Results
MtDNA mutation load in epithelial crypts compared
with smooth muscle fibres
The load of the m.3243A>G mutation was lower
in crypts laser-microdissected from the mucosa
comparedwith fibres from the smoothmuscle in oesoph-
agus (p< 0.0001, Mann–Whitney U-test), stomach
(p< 0.0001, unpaired t-test), the small intestines
(SI) (p< 0.05 for patient 1 and p< 0.0001 for patient 2,
unpaired t-test andMann–WhitneyU-test respectively),
and colon (p< 0.005, unpaired t-test) (Figure 1B). In
addition, our studies showed a markedly lower hetero-
plasmy in the mitotic epithelium than in the smooth
muscle of colon from the patient with the m.8344A>G
mutation (p< 0.0001, unpaired t-test) (Figure 1B). The
mutation load in the epithelium was notably variable,
with no detectable mutation in some of the intestinal
crypts and oesophageal epithelium. We did not observe
any crypts with m.3243A>G higher than 86% or any
oesophageal epithelium with m.3243A>G higher than
51%. The colonic epithelium also showed an upper
threshold for m.8344A>G of approximately 80%. In
most cases, the level in the mucosal epithelium was also
Figure 2. Deficient COX activity in post-mitotic smooth muscle but
normal COX activity in mitotic epithelium of the alimentary canal
in patients with inherited m.3243A>G. The left panel shows the
COX-normal epithelium that is labelled brown in the SI of patient 1,
and the oesophagus, the stomach, and the SI of patient 2, while the
right panel manifests the blue COX-deficient muscle fibres in these
tissues. The control panel shows the COX-normal epithelium (black
arrow) and smooth muscle from a normal individual who also has
crypts with defective COX activity (red arrow), due to accumulated
somatic mtDNA mutations during ageing. Scale bar= 50 μm.
lower than other post-mitotic tissues such as skeletal and
cardiac muscle, suggesting a loss of mutation overall
(supplementary material, Table S2).
Enzyme activity and protein level of OXPHOS
complexes
The m.3243A>G mutation in the tRNALeu(UUR) gene
impairs mitochondrial protein synthesis, causing defects
in single or multiple respiratory chain complexes,
including complex I and complex IV (COX) enzyme
activity [15]. We hypothesised that if the inherited
pathogenic mutation was lost in the epithelium, this
would alleviate the mitochondrial biochemical defect
within the tissue [15]. Sequential COX/SDH histochem-
istry showed very little COX activity in the post-mitotic
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Figure 3. Protein levels of complex I were normal in the mitotic epithelium along the gastrointestinal tract but deficient in the post-mitotic
smooth muscles. (A) Example of immunofluorescence images showing the levels of NDUFB8 (complex I) (green) and COX4 (red), a nuclear
encoded subunit that is not compromised by the m.3243A>G mutation. (B) Quantative measurement of the protein level of NDUFB8.
Z-scores of NDUFB8 for each patient were calculated and categorised based on the age-matched control population. The numbers of crypts
for quantification were as follows: n (P1 SI)= 70; n (control)=128; n (P2 SI)= 28; n (control)= 48; n (P2 stomach)= 6; n (control)= 36; n (P3
colon)= 20; n (control)= 91. Oesophageal epithelium and colonic smooth muscle from the whole section were selected for quantification.
Patient data were compared with data from two controls for the stomach; three controls for the colon, the oesophagus, and the SI of
patient 2; and four controls for the SI of patient 1. E = epithelium. M=muscle. Scale bar= 50 μm
smooth muscle of all three regions of the gastrointestinal
tract. However, COX activity was largely preserved in
the epithelial cells (Figure 2). We detected no COX
deficiency in the oesophagus and SI of patient 2, and
only 1.25% COX deficiency in the SI epithelium of
patient 1, 2.67% in the stomach epithelium of patient
2, and 2.59% in the large intestinal epithelium of
patient 3.
Since there is no reliable histochemical assay for
complex I, we used immunofluorescence to quantify the
levels of NDUFB8, a subunit of respiratory chain com-
plex I critical to the complex assembly and often lost
in OXPHOS deficiency [14]. NDUFB8 showed normal
expression in the epithelium of the colon, oesophagus,
stomach, and SI of the patients (Figure 3) compared
with age-matched controls. In contrast, NDUFB8 was
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low with 50% deficiency in the post-mitotic smooth
muscle of the colon from patients compared with
age-matched controls (Figure 3). We found higher lev-
els of nuclear encoded mitochondrial proteins, SDHA
and COX4, both of which are reported to be preserved
in tissues with mtDNA defects [16], in the epithelium
of the patients’ oesophagus (47.62% and 40.91%,
respectively), stomach (14.29% for SDHA), and SI
(10% in patient 2 for SDHA; 8.57% in patient 1 and
14.29% in patient 2 for COX4) (supplementary material,
Figure S1). SDHA also increased in the colonic muscle
of the patient (27.27% (Figure S1)). This is likely a
compensatory response.
Discussion
Understanding the behaviour of mtDNA mutations
in different tissues is critical not only to understand-
ing the phenotype of inherited mtDNA disease but
also in our understanding of the impact of acquired
mtDNAmutations seen in human ageing. Here, we have
investigated multiple epithelial tissues from patients
with inherited mtDNA mutations and have shown a
significantly lower mtDNA mutation level in epithelial
cells compared with the post-mitotic smooth muscle
fibres of the oesophagus, the stomach, and the small
and the large intestine. We show that the mutation
level is correlated with the finding of normal COX
activity and complex I protein levels in epithelial cells,
but deficient COX activity and low complex I protein
expression in the post-mitotic smooth muscle from
the same patients. The finding of respiratory chain defi-
ciency in the gastrointestinal smooth muscle is similar
to previous reports [17] and entirely consistent with the
severe symptoms of bowel dysmotility in many patients
with mitochondrial disease.
Previous reports in foetal tissues show that the level
of mtDNA mutation was largely uniform in all tis-
sues [6–8]. Given that there is little evidence that the
mutation burden changes with age in muscle [10], our
results suggest a loss of inherited mtDNA mutation in
the mitotic gastrointestinal epithelium with age. This
is consistent with previous reports showing a loss of
the m.3243A>G mutation in patients’ blood over time
[9,10]. However, as all of our patients are adults, the
exact time of the loss remains unknown. It is known that
m.3243A>G mutation load is the same in all tissues
during embryo development and fetal growth [6–8]
and the studies in blood (where serial measurements
are possible) show loss of mutation throughout life but
most markedly in the early years [9,10]. Whilst we have
a very small patient cohort, we did determine if there
was a trend for more mutation loss in epithelial cells
in the older patient (64 years) when compared with the
same type of epithelial tissue from the younger patient
(30 years). We did not detect a difference but previous
studies in blood have shown considerable individual
variation and a slowing down of selection after early
adult life [10].
The site of the loss of mutation in mitotic tissues is
unknown but previous in silico modelling suggests that
the selective loss occurs in haematopoietic stem cells
[18]. Intestinal crypts have stem cells at the base with
amplifying cells and differentiated progenies present in
the crypt. Crypts also undergo monoclonal conversion
until a whole crypt derives from a single stem cell [19].
In this context, the pattern of mtDNAmutation load seen
in crypts is interesting since it shows marked variation
in the level, with some crypts carrying no detectable
mutation. This strongly indicates that selection against
the mutation is occurring at the stem cell level since
selection at any other stage is unlikely to result in
no detectable mutation. The overall marked decrease
in the mutation level and the upper cut-off threshold in
the intestinal crypts imply a negative selection against
the mutations, not a bidirectional random genetic drift.
These observations in intestinal crypts in patients
with mtDNA disease are in marked contrast to the
observation in normal ageing of human gastrointesti-
nal stem cells, where mitochondrial DNA mutations
accumulate somatically up to homoplasmy, resulting in
OXPHOS deficiency [4,12,20]. In contrast to our data
for inherited mtDNA mutations, there is no evidence
of any selective pressures on these somatic mtDNA
mutations [21]. The difference in the selective pressures
on somatic and inherited mtDNA mutations remains
unknown but indicates significant changes in stem cell
biology in the normal ageing process.
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